About RxAll
RxAll is a company based in New Haven (United States) founded in 2015 by Adebayo Alonge and Ankur Kapadia. RxAll has raised $5.35 million across 5 funding rounds from investors including Katapult, Launch Africa and HAX. RxAll offers products and services including RxScanner, RxDelivered, RxPay, and RxPOS. RxAll operates in a competitive market with competitors including TruTag Technologies, Meditect, Sproxil, PharmaSecure and InfraTrac, among others.
- Headquarter New Haven, United States
- Founders Adebayo Alonge, Ankur Kapadia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rxall, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.35 M (USD)
in 5 rounds
-
Latest Funding Round
$3.15 M (USD), Seed
Jul 20, 2021
-
Investors
Katapult
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RxAll
RxAll offers a comprehensive portfolio of products and services, including RxScanner, RxDelivered, RxPay, and RxPOS.
AI device for authenticating drug quality in real-time.
Secure platform connecting buyers and sellers of verified medicines.
Funding solution to prevent stock-outs for pharmacies and wholesalers.
Software for automating sales, inventory, and payments in pharmacies.
People of RxAll
Unlock access to complete
Unlock access to complete
Funding Insights of RxAll
RxAll has successfully raised a total of $5.35M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $3.15 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RxAll
RxAll has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Katapult, Launch Africa and HAX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked | |
|
Startups are accelerated via a 111-day program with seed funding.
|
Locked | Locked | Locked | |
|
Investment consulting services are provided to guide client portfolios.
|
Locked | Locked | Locked |
Investor details for RxAll
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RxAll
Investment portfolio details for RxAll
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RxAll
Detailed financials for RxAll
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rxall Comparisons
Peer comparison for RxAll
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RxAll
RxAll operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TruTag Technologies, Meditect, Sproxil, PharmaSecure and InfraTrac, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Anti-counterfeiting solutions are offered via microscopic edible barcodes for authentication.
|
|
| Locked | Locked | Locked |
Falsified medicines are tracked via AI and blockchain software.
|
|
| Locked | Locked | Locked |
Mobile technology is deployed to authenticate products against counterfeits.
|
|
| Locked | Locked | Locked |
Medication authenticity is verified through SMS by PharmaSecure.
|
|
| Locked | Locked | Locked |
Chemical code tagging solutions are used for counterfeit detection.
|
Detailed competitors of RxAll
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rxall
Complete news archive for RxAll
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RxAll
RxAll was founded in 2015 and raised its 1st funding round 2 years after it was founded.
RxAll is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Adebayo Alonge is the current CEO of RxAll. They have also founded this company.
RxAll is a funded company, having raised a total of $5.35M across 5 funding rounds to date.
RxAll was founded in 2015 in New Haven, United States, within the health technology sector. An AI-based platform is utilized to enable real-time authentication of medicines through spectrometer devices. Deep learning algorithms are applied alongside a cloud dataset of spectral signatures to perform non-destructive verification. Operations include a digital procurement system that allows hospitals and retail pharmacies to source authentic stock from verified pharmaceutical manufacturers and wholesalers.
RxAll's top competitors include TruTag Technologies, Meditect and PharmaSecure.
RxAll offers RxScanner, RxDelivered, RxPay, and RxPOS.
RxAll has 4 investors. Key investors include Katapult, Launch Africa, HAX, and Keisuke Honda.